week 10 Neurodevelopmental/Neurocognitive DOs

Question 1

when might a drug like GUANFACINE (non-stimulant) be used to Tx ADHD?

Answer 1

if stimulants are not working
if stimulants cause too many SEs
if child/teen has SUD
if child/teen has another cond. where stimulants cant be used (e.g., tic DO)

Question 2

what alpha-2 agonists are used second-line to Tx ADHD if first line cannot be used d/t SEs/ineffectiveness?

Answer 2

clonidine

guanfacine

Question 3

——what atypical antipsychotics can be used in ASD?

and what must be monitored for?

Answer 3

……

sedation

Question 4

what are the SEs of COGENTIN in the elderly?

Answer 4

anticholinergic (dry mouth, confusion, blurred vision, urinary retention, constipation etc) ALWAYS REVIEW MEDS n BE CAUTIOUS OF THIS

Question 5

—-whats first line Tx for IDD?

Answer 5

…..

Question 6

—–whats first line Tx for ADHD?

Answer 6

…..

Question 7

—–what labs should be obtained before starting ADHD meds?

Answer 7

…..

Question 8

—–• What are the stimulant and nonstimulant options when treating ADHD/ADD?

Answer 8

…..

Question 9

—–• What formulations are available for stimulants? What are the pros and cons of each formulation?

Answer 9

…..

Question 10

—–• What are the side effects of stimulants? Should you be concerned? If so, what would you monitor?

Answer 10

…..

Question 11

—–When treating a patient with IDD, what should you consider when treating them with psychopharmacologic agents?

Answer 11

…..

Question 12

—–Should clinicians screen for other psychiatric disorders when screening for ADHD?

Answer 12

…..

Question 13

—–What is the clinical implications of treating ADHD in a patient with other disorders, such as anxiety and mood disorders?

Answer 13

…..

Question 14

—–Can stimulants play a role in treating depression?

Answer 14

…..

Question 15

—–• How would you treat aggression in a client with autism?

Answer 15

…..

Question 16

—-• How do you treat agitation in the patient with dementia?

Answer 16

…..

Question 17

—–• Do you dose elderly/geriatric population differently than the adult population when treating acute agitation? If so, why?

Answer 17

…..

Question 18

—–• What pharmacologic agents should you avoid when treating depression/anxiety and agitation in the client with neurocognitive disorders? Why?

Answer 18

…..

Question 19

—–• Causes and treatment for sexual dysfunctions such as premature ejaculation, erectile dysfunction and hypoarousal?

Answer 19

….

Question 20

—–• Would a reduction of antidepressant dose be helpful in sexual dysfunction?

Answer 20

…..

Question 21

If a child is taking their medication twice daily (i.e. at home and school) and parents request to solely administer the medication= consider switching to what??

Answer 21

Methylphenidate CD= extended-release